JOEL LEWIS, President & CEO, Director at Galectin Therapeutics, holds 899.01K shares in Galectin Therapeutics (Ticker: GALT). Most recently, JOEL LEWIS Bought $1,000 shares of Galectin Therapeutics on Apr 25, 2024 for an estimated value of 3.39K.
What is the percentage of profitable transactions made by JOEL LEWIS?
The percentage of profitable transactions made by JOEL LEWIS is 14%.
What is the average return per transaction made by JOEL LEWIS?
The average return per transaction made by JOEL LEWIS is -29.00%.
What stocks does JOEL LEWIS hold?
JOEL LEWIS holds: GALT stocks.
What was JOEL LEWIS’s latest transaction?
JOEL LEWIS latest transaction was an Informative Buy of $3.39K.
What was JOEL LEWIS's most profitable transaction?
JOEL LEWIS’s most profitable transaction was an Informative Buy of GALT stock on February 21, 2023. The return on the trade was 16.20%.
What is JOEL LEWIS's role in Galectin Therapeutics?
JOEL LEWIS's role in Galectin Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.